Danaher spin-off Envista soars on 1st day of trading

2019 09 18 22 27 1930 Stock Exchange 400

Envista Holdings, the dental spin-off of Danaher, raised almost $590 million from an initial public offering completed September 18.

The company sold nearly 27 million shares at $22 a share on the first day it was available. Shares closed at just under $28 per share, up 27%.

Envista is the parent company of KaVo Kerr, Nobel Biocare, and Ormco.

Page 1 of 66
Next Page